You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – Danaher today said that it has completed its $19.50-per-share offer to acquire Iris International.
NEW YORK (GenomeWeb News) – Danaher announced late Monday the extension of its tender offer for Iris International to 5 p.m. EDT on Oct. 31 due to Hurricane Sandy.
NEW YORK (GenomeWeb News) – Danaher today said it is extending its tender offer for Iris International to midnight EDT, Oct. 29 in order to allow investors time to consider new disclosures by Iris.
NEW YORK (GenomeWeb News) – Danaher today said that it has signed definitive agreement to acquire diagnostics and sample prep technologies firm Iris International for $19.50 per share in cash.
NEW YORK (GenomeWeb News) – Kreatech Diagnostics today announced a distribution agreement covering Iris Sample Processing's automated fluorescent in situ hybridization sample preparation product.
Seegene this week announced the commercial availability outside of the US of the Anyplex II RV16 detection assay, the second real-time qPCR assay based on the company's TOCE technology.
NEW YORK (GenomeWeb News) – Iris International today announced that the US Food and Drug Administration has granted 510(k) clearance for its Nadia ProsVue prognostic cancer test for prostate cancer.
The deal gives Iris a CLIA-certified molecular pathology laboratory and a direct commercial channel for acceleration of its NADiA platform.
President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.
Wired reports that Oxitec has now developed a genetically modified fall armyworm.
A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.
In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.